BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright ©The Author(s) 2025.
World J Diabetes. Sep 15, 2025; 16(9): 107871
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.107871
Figure 1
Figure 1 Forest plot of the effect of inositol supplementation on gestational diabetes mellitus incidence.
Figure 2
Figure 2 Forest plot regarding the gestational diabetes mellitus rate. Baseline characteristics balanced across all studies. CI: Confidence interval; DL: DerSimonian-Laird.
Figure 3
Figure 3 Funnel plot. A: Funnel plot for gestational diabetes mellitus incidence analysis; B: Funnel plot for 2-hour oral glucose tolerance test analysis.
Figure 4
Figure 4 Fasting plasma glucose. A: Forest plots of secondary outcomes; B: Sensitivity analysis; C: Adjusted forest plot. CI: Confidence interval; DL: DerSimonian-Laird.
Figure 5
Figure 5 One-hour oral glucose tolerance tests. A: Forest plots of secondary outcomes; B: Sensitivity analysis; C: Adjusted forest plot. CI: Confidence interval; DL: DerSimonian-Laird.
Figure 6
Figure 6 Two-hour oral glucose tolerance tests. A: Forest plots of secondary outcomes; B: Sensitivity analysis; C: Adjusted forest plot. CI: Confidence interval; DL: DerSimonian-Laird.
Figure 7
Figure 7 Forest plots of secondary outcomes. A: Preterm birth; B: Pregnancy-induced hypertension; C: Cesarean section rate; D: Macrosomia; E: Birth weight; F: Neonatal hypoglycemia; G: Gestational age at birth. CI: Confidence interval; DL: DerSimonian-Laird.